Cabaletta Bio to Present at Key Global Healthcare and Immunology Conferences
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced its participation in several major investor and healthcare conferences through November and December 2025, where company leadership will discuss ongoing progress …
Cabaletta Bio to Present at Key Global Healthcare and Immunology Conferences Read More